# K0706 for Patients Diagnosed With Dementia With Lewy Bodies

> **NCT03996460** · PHASE2 · RECRUITING · sponsor: **Georgetown University** · enrollment: 45 (estimated)

## Conditions studied

- Dementia With Lewy Bodies

## Interventions

- **DRUG:** Placebo
- **DRUG:** 192 mg powder of K0706
- **DRUG:** 384 mg powder of K0706

## Key facts

- **NCT ID:** NCT03996460
- **Lead sponsor:** Georgetown University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-09-05
- **Primary completion:** 2023-06
- **Final completion:** 2023-10
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2022-10-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03996460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03996460, "K0706 for Patients Diagnosed With Dementia With Lewy Bodies". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03996460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*